Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea 314930
Biohit Oyj Logo
Develops diagnostic tests and lab systems for healthcare, research, and industrial laboratories.
Finland BIOBV
BIONEERCORPORATION Logo
Provides molecular biology tools & diagnostic kits for research and clinical applications.
South Korea 064550
BioNote, Inc. Logo
Manufactures veterinary diagnostics, analyzers, and software for animal health professionals.
South Korea 377740
Develops & manufactures HA-based biomaterials & medical devices for aesthetics & medical sectors.
South Korea 099430
Bioretec Oy Logo
Develops bioabsorbable orthopedic implants for adults & children, eliminating removal surgery.
Finland BRETEC
Boditech Med Inc. Logo
Develops & manufactures rapid point-of-care in-vitro diagnostic solutions for medical pros.
South Korea 206640
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium MLBON
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden BOUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.